Clinical Trials List
Protocol Number1200.26
2008-09-01 - 2010-12-31
Phase II
Terminated3
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 陳祁安 Division of Obstetrics & Gynecology
- Chih-Hung Hsu Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- Wen-Fang Cheng Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Hung-Ming Wang Division of Hematology & Oncology
- Hsien-Kun Chang Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- 廖宗琦 Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Cheng-Lung Hsu Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Tsai-Yun Chen Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
60 participants
